Ginkgo Bioworks Holdings

Ginkgo Bioworks Holdings

Life Sciences Tools & Services
Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering: where company provide biological R&D services for customers across a range of industries and Biosecurity: where it provide services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.

$447.1M

Market Cap • 9/11/2026

2008

(18 years)

Founded

2021

(5 years ago)

IPO

NYSE

Listing Exchange

Flag of United States

United States

Country

Valuation

P/B

1,1

P/S

4

P/EBITDA

P/OCF

P/FCF

P/E

BVPS

7,2

EPS

Market Cap

Market Cap

447,1M

EV

549,1M

EV/Revenue

4,9

EV/EBITDA

-2,3

EV/EBIT

-1,9

Payout

Dividend Per Share

0

Dividend Yield

0%

Buyback Yield

-8,2%

Total Yield

-8,2%

Payout

0%

Retained Earnings

-6,3B

Profitability

Gross Margin

77,7%

EBITDA Margin

EBIT Margin

Net Margin

D&A/EBITDA

0%

R&D/Revenue

192,7%

Capex/Revenue

4,1%

Capex/D&A

8,5%

Capex/OCF

-2,7%

SBC/OCF

% PPE

51%

% Goodwill

0%

ROE

ROIC

Growth

CAGR Revenue 5Y

-3,4%

CAGR Op. Income 5Y

7%

CAGR Net Income 5Y

16%

CAGR EPS 5Y

-4,8%

Leverage

N.D./EBITDA

Debt/Equity

0%

Current Ratio

4,6

Quick Ratio

4,3

Interest Coverage

Premium

Unlock 100% of the data and have immediate access on more than 6.000 companies with updated information!
  • Unrestricted access
  • Unlimited data history
  • Analysis videos
  • Quarterly highlights
  • Customizable financials table
  • Ranking
  • Discussions

...and much more!

Get Premium